TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)

Taiwan · Delayed Price · Currency is TWD

11.35

+0.05 (0.44%)

Mar 24, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
New Drug Development and Drug Sales		149.15M	119.15M	36.23M	1.29B	23.42M
New Drug Development and Drug Sales Growth		25.18%	228.87%	-97.20%	5426.95%	31.74%
Pharmaceutical Technology Consultancy		1.50M	3.99M	-	-	-
Pharmaceutical Technology Consultancy Growth		-62.34%	-	-	-	-
Total		150.65M	123.13M	36.23M	1.29B	23.42M
Total Growth		22.35%	239.87%	-97.20%	5426.95%	15.30%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan		38.78M	30.57M	21.03M	8.14M	6.15M
Taiwan Growth		26.84%	45.36%	158.45%	32.31%	-29.95%
Mainland China		111.88M	92.57M	-	1.24B	13.72M
Mainland China Growth		20.86%	-	-	8953.58%	18.94%
Russia		-	-	15.20M	-	3.46M
South Korea		-	-	-	44.23M	-
Others		-	-	-	-	92.00K
Total		150.65M	123.13M	36.23M	1.29B	23.42M
Total Growth		22.35%	239.87%	-97.20%	5426.95%	15.30%

Source: S&P Global Market Intelligence.